Paradigm Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Paradigm Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.78M	Hold	29,408	–	–	0.42%	74
2025 Q4	$1.59M	Sell	29,408 -1,600	-5%	-$77K	0.37%	99
2025 Q3	$1.4M	Hold	31,008	–	–	0.32%	118
2025 Q2	$1.44M	Sell	31,008 -8,400	-21%	-$412K	0.35%	106
2025 Q1	$2.4M	Hold	39,408	–	–	0.64%	36
2024 Q4	$2.23M	Buy	39,408 +6,400	+19%	+$358K	0.61%	33
2024 Q3	$1.71M	Hold	33,008	–	–	0.45%	70
2024 Q2	$1.37M	Sell	33,008 -12,800	-28%	-$573K	0.38%	87
2024 Q1	$2.48M	Sell	45,808 -1,300	-3%	-$66.2K	0.63%	29
2023 Q4	$2.42M	Sell	47,108 -1,200	-2%	-$63K	0.64%	25
2023 Q3	$2.8M	Sell	48,308 -2,400	-5%	-$147K	0.79%	15
2023 Q2	$3.24M	Buy	50,708 +47,100	+1,305%	+$3.16M	0.87%	13
2023 Q1	$250K	Sell	3,608 -200	-5%	-$14.1K	0.07%	262
2022 Q4	$274K	Sell	3,808 -51,240	-93%	-$3.86M	0.08%	263
2022 Q3	$3.91M	Sell	55,048 -800	-1%	-$58K	1.31%	4
2022 Q2	$4.3M	Buy	55,848 +2,200	+4%	+$168K	1.32%	4
2022 Q1	$3.92M	Hold	53,648	–	–	1.03%	12
2021 Q4	$3.34M	Buy	53,648 +3,808	+8%	+$223K	0.84%	19
2021 Q3	$2.95M	Sell	49,840 -2,400	-5%	-$158K	0.81%	20
2021 Q2	$3.49M	Hold	52,240	–	–	0.89%	12
2021 Q1	$3.3M	Sell	52,240 -1,500	-3%	-$93.3K	0.88%	12
2020 Q4	$3.33M	Buy	53,740 +37,000	+221%	+$2.28M	0.93%	9
2020 Q3	$1.01M	Sell	16,740 -2,700	-14%	-$163K	0.31%	104
2020 Q2	$1.14M	Sell	19,440 -3,900	-17%	-$233K	0.35%	83
2020 Q1	$1.3M	Hold	23,340	–	–	0.5%	42
2019 Q4	$1.5M	Buy	23,340 +850	+4%	+$48.7K	0.45%	55
2019 Q3	$1.14M	Sell	22,490 -4,800	-18%	-$226K	0.37%	81
2019 Q2	$1.24M	Buy	27,290 +4,950	+22%	+$231K	0.36%	97
2019 Q1	$1.07M	Sell	22,340 -950	-4%	-$47.3K	0.31%	117
2018 Q4	$1.21M	Buy	23,290 +1,000	+4%	+$53.7K	0.39%	83
2018 Q3	$1.38M	Sell	22,290 -20,600	-48%	-$1.22M	0.39%	83
2018 Q2	$2.37M	Hold	42,890	–	–	0.69%	47
2018 Q1	$2.71M	Sell	42,890 -2,800	-6%	-$180K	0.79%	27
2017 Q4	$2.8M	Sell	45,690 -4,600	-9%	-$288K	0.77%	30
2017 Q3	$3.21M	Sell	50,290 -17,666	-26%	-$1.03M	0.83%	22
2017 Q2	$3.79M	Buy	67,956 +4,100	+6%	+$223K	0.76%	42
2017 Q1	$3.47M	Sell	63,856 -13,321	-17%	-$731K	0.66%	56
2016 Q4	$4.51M	Buy	77,177 +15,100	+24%	+$826K	0.87%	34
2016 Q3	$3.35M	Sell	62,077 -600	-1%	-$38.5K	0.58%	71
2016 Q2	$4.61M	Sell	62,677 -3,323	-5%	-$235K	0.8%	46
2016 Q1	$4.22M	Sell	66,000 -1,100	-2%	-$69.4K	0.78%	40
2015 Q4	$4.62M	Sell	67,100 -1,600	-2%	-$106K	0.79%	43
2015 Q3	$4.07M	Sell	68,700 -4,000	-6%	-$254K	0.53%	64
2015 Q2	$4.84M	Buy	72,700 +700	+1%	+$46.1K	0.54%	66
2015 Q1	$4.64M	Buy	72,000 +7,800	+12%	+$488K	0.52%	71
2014 Q4	$3.79M	Buy	+64,200	New	+$3.62M	0.49%	72
2014 Q3	–	Sell	-89,100	Closed	-$4.32M	–	791
2014 Q2	$4.32M	Buy	89,100 +4,800	+6%	+$237K	0.58%	46
2014 Q1	$4.38M	Buy	84,300 +18,700	+29%	+$995K	0.6%	43
2013 Q4	$3.49M	Sell	65,600 -3,000	-4%	-$153K	0.53%	42
2013 Q3	$3.17M	Sell	68,600 -5,200	-7%	-$228K	0.52%	48
2013 Q2	$3.3M	Buy	+73,800	New	+$3.2M	0.57%	39

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paradigm Asset Management's BMY Position: Q1 2026 in Review

Paradigm Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 29,408 shares worth $1.78M. The position accounts for 0.42% of the portfolio, ranked #74.

Paradigm Asset Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $4.84M in Q2 2015. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Paradigm Asset Management held 29,408 shares of Bristol-Myers Squibb worth $1.78M as of Q1 2026.
Paradigm Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.42% of Paradigm Asset Management's portfolio in Q1 2026, its #74 holding.
Paradigm Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
Paradigm Asset Management's Bristol-Myers Squibb position peaked at $4.84M in Q2 2015.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.